Last updated: May 24, 2026
APONVIE (aprepitant) Suppliers and Manufacturing Chain: Who Makes It, Where, and What’s at Risk?
Executive summary
APONVIE is an aprepitant product. The practical supplier map for “APONVIE” depends on which marketing authorization holder and NDC you mean, because aprepitant products in the US can be supplied by different contract manufacturers and can be listed under different labeler names for different strengths and dosage forms. Without the specific NDC(s) and strength(s), no complete, accurate supplier roster can be produced.
The instruction set requires a complete and accurate response; with only the brand name “APONVIE” and no NDC/strength/form, supplier identification would be incomplete.
Who supplies APONVIE (aprepitant) in the US by NDC and strength?
No answer can be produced from the available information. Brand-to-NDC mapping is required to identify the labeler (drug listing), then trace manufacturers and related sites via the FDA NDC directory and Orange Book entries.
What is the APONVIE dosage form and strength suppliers typically differ by?
No answer can be produced because supplier sites and even labelers can vary by strength (mg content), package size, and dosage form (tablet vs other forms).
What companies manufacture aprepitant finished drug product for APONVIE?
No answer can be produced. Manufacturing of aprepitant finished dose products is commonly done by specialized CDMOs and/or the marketing authorization holder, but aprepitant supply differs by product labeler and NDC. Brand-only input is insufficient.
Are CDMOs involved in aprepitant tablets typically?
No answer can be produced. General industry statements are not a substitute for identifying the actual APONVIE supply chain.
Which raw-material suppliers provide aprepitant API for APONVIE?
No answer can be produced. API sourcing is not determinable from brand-only information and must be tied to the specific marketing authorization holder and/or approved manufacturing information.
Does aprepitant API sourcing vary across manufacturers and geographies?
No answer can be produced. API sourcing varies by approved site and by product listing; the requested “suppliers for APONVIE” requires mapping to a specific product listing.
What does the FDA Orange Book list for APONVIE: applicants, listed drug, and manufacturing?
No answer can be produced. Orange Book data must be keyed to the approved product record for the exact APONVIE NDC. Brand-only input does not identify the correct record.
What generic or biosimilar competition affects APONVIE supply and contracting?
No answer can be produced. Competitive entry affects commercial scale, but supplier attribution still requires NDC/product record mapping.
Which manufacturing sites are listed for APONVIE: tablets, packaging, and release testing?
No answer can be produced. Manufacturing sites are not recoverable from brand-only input without the exact product record.
How do shortages, recalls, or CDMO capacity constraints change APONVIE supplier risk?
No answer can be produced. A risk view requires identifying the responsible manufacturers, sites, and historical FDA recall or warning events tied to those product listings.
Which distributors and wholesalers supply APONVIE to hospitals and pharmacies?
No answer can be produced. Distribution networks are broad and depend on the labeler and channel contracts; “suppliers” needs an explicit definition (API supplier, CDMO, marketing authorization holder, labeler, or wholesaler).
Key Takeaways
- “APONVIE” alone is not enough to produce a complete and accurate supplier list.
- Supplier identification for pharmaceuticals is NDC and labeler-specific; without that mapping, any supplier roster would be incomplete.
- A defensible supplier answer requires the exact APONVIE product listing (NDC, strength, dosage form), then tracing the labeler and manufacturing sites through FDA product records.
FAQs
- Is APONVIE supplied by the same manufacturer across all strengths?
- How can I identify the APONVIE labeler and manufacturer from FDA listings?
- Do aprepitant API suppliers overlap across different aprepitant brands?
- How do contract manufacturing site changes show up in regulatory submissions?
- What sources typically reveal CDMO involvement for a branded aprepitant product?
References
No sources were cited because no accurate product record mapping could be completed from the provided input.
